日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis

一项多中心、随机、安慰剂对照试验，研究阿托伐他汀在类风湿性关节炎患者心血管事件一级预防中的疗效

期刊:Arthritis & Rheumatology
影响因子:10.9
doi:10.1002/art.40892
Kitas, George D; Nightingale, Peter; Armitage, Jane; Sattar, Naveed; Belch, Jill J F; Symmons, Deborah P M
关节炎
发表日期：2019
文献求助 收藏

Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register

接受肿瘤坏死因子α抑制剂治疗的重度银屑病关节炎患者的恶性肿瘤发生率和死亡率：来自英国风湿病学会生物制剂注册研究的结果

期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/key241
Fagerli, Karen M; Kearsley-Fleet, Lianne; Mercer, Louise K; Watson, Kath; Packham, Jon; Symmons, Deborah P M; Hyrich, Kimme L
关节炎
银屑病
肿瘤免疫
肿瘤
发表日期：2019
文献求助 收藏

Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease

系统评价他汀类药物依从性预测因素在心血管疾病一级预防中的作用

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0201196
Hope, Holly F; Binkley, George M; Fenton, Sally; Kitas, George D; Verstappen, Suzanne M M; Symmons, Deborah P M
心血管疾病
心血管
发表日期：2019
文献求助 收藏

Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity

并非所有中度疾病都相同——识别类风湿关节炎中度活动患者的残疾轨迹

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0215999
Pan, Yi; Norton, Sam; Gwinnutt, James M; Kearsley-Fleet, Lianne; Symmons, Deborah P M; Lunt, Mark; Young, Adam; Hyrich, Kimme L; Verstappen, Suzanne M M
关节炎
发表日期：2019
文献求助 收藏

Have the 10-year outcomes of patients with early inflammatory arthritis improved in the new millennium compared with the decade before? Results from the Norfolk Arthritis Register

与上个十年相比，新千年以来早期炎症性关节炎患者的十年预后是否有所改善？来自诺福克关节炎登记处的研究结果。

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/annrheumdis-2017-212426
Gwinnutt, James M; Symmons, Deborah P M; MacGregor, Alexander J; Chipping, Jacqueline R; Marshall, Tarnya; Lunt, Mark; Verstappen, Suzanne M M
炎症/感染
关节炎
炎症
发表日期：2018
文献求助 收藏

Long-term persistence of TNF-inhibitor treatment in patients with psoriatic arthritis. Data from the British Society for Rheumatology Biologics Register

TNF抑制剂治疗银屑病关节炎患者的长期疗效：数据来自英国风湿病学会生物制剂注册库

期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2017-000596
Fagerli, Karen Minde; Kearsley-Fleet, Lianne; Watson, Kath D; Packham, Jon; Contributors Group, Bsrbr-Ra; Symmons, Deborah P M; Hyrich, Kimme L
关节炎
银屑病
发表日期：2018
文献求助 收藏

Prediction of primary non-response to methotrexate therapy using demographic, clinical and psychosocial variables: results from the UK Rheumatoid Arthritis Medication Study (RAMS)

利用人口统计学、临床和心理社会变量预测甲氨蝶呤治疗的原发性无反应：英国类风湿性关节炎药物研究（RAMS）的结果

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-018-1645-5
Sergeant, Jamie C; Hyrich, Kimme L; Anderson, James; Kopec-Harding, Kamilla; Hope, Holly F; Symmons, Deborah P M; Barton, Anne; Verstappen, Suzanne M M
关节炎
药物研究
多发性硬化症
发表日期：2018
文献求助 收藏

Risk factors for oral methotrexate failure in patients with inflammatory polyarthritis: results from a UK prospective cohort study

炎性多关节炎患者口服甲氨蝶呤治疗失败的危险因素：英国前瞻性队列研究的结果

期刊:Arthritis Research & Therapy
影响因子:4.4
doi:10.1186/s13075-018-1544-9
James Bluett, Jamie C Sergeant, Alex J MacGregor, Jacqueline R Chipping, Tarnya Marshall, Deborah P M Symmons, Suzanne M M Verstappen
免疫
关节炎
发表日期：2018
文献求助 收藏

Long-term persistence with rituximab in patients with rheumatoid arthritis

利妥昔单抗在类风湿性关节炎患者中的长期疗效

期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/key036
Oldroyd, Alexander G S; Symmons, Deborah P M; Sergeant, Jamie C; Kearsley-Fleet, Lianne; Watson, Kath; Lunt, Mark; Hyrich, Kimme L
关节炎
发表日期：2018
文献求助 收藏

Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

接受利妥昔单抗治疗或在初始TNF抑制剂治疗失败后接受第二种TNF抑制剂治疗的类风湿关节炎患者，在1年后发生严重感染的风险：来自英国风湿病学会类风湿关节炎生物制剂注册研究的结果

期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/kex304
Silva-Fernández, Lucía; De Cock, Diederik; Lunt, Mark; Low, Audrey S; Watson, Kath D; Symmons, Deborah P M; Hyrich, Kimme L
炎症/感染
关节炎
发表日期：2018
文献求助 收藏